Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: Long-field of view PET/CT scanners allows total body scanning resulting higher sensitivity than traditional PET/CT scanners offering possible lower dose and faster scans.
Conference:
Presenting Author: Santillan N
Authors: Navalkissoor S, Santillan N, Chowdhury A, Ferreira B, Toumpanakis C,
Keywords: SSR, Ga68 DOTATATE, Neuroendocrine tumour, Quadra,
Introduction: The introduction of peptide receptor radionuclide therapy (PRRT) to the Philippines has allowed for novel approaches in the management of neuroendocrine tumors (NETs).
Conference:
Presenting Author: Chianpian C
Authors: Chianpian C, Bautista-Peñalosa P, Santos C, Bandong I,
Keywords: peptide receptor radionuclide therapy, metastatic pancreatic neuroendocrine tumor, Ga-68 DOTATATE, Lu-177 DOTATATE, Philippines,
Introduction: Liver metastases (LM) from well-differentiated (G1/2) neuro-endocrine tumor (NET) can be managed by peptide-receptor radiotherapy (PRRT). Grading determination requires a biopsy; however, biological features can be heterogenous across metastases. Moreover, time-to-progression (TTP) after PRRT can be widely variable.
Conference:
Presenting Author: Fiz F
Authors: Fiz F, Centurioni G, La Fougère C,
Keywords: PRRT, Radiomics, Texture Analysis, PET, PET/CT,
Introduction: Neuroendocrine tumors (NET) are heterogeneous neoplasms. The choice of the appropriate molecular imaging study for assessment of disease extent usually depends on tumor grade.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author:
Authors: Rossi R, Barker A, Luong T, Navalkissoor S, Quigley A,
Keywords: neuroendocrine tumor, histology, functional imaging,
#590 Imaging of Metastatic-Recurrent Paragangliomas and Pheochromocytomas with Ga-68 DOTATATE PET/CT
Introduction: Approximately 73% of Pheochromocytomas(Pheo) and 93% of paragangliomas(PGL) express somatostatin receptors and Ga-68 DOTATATE PET/CT may have a role in metastatic PHEO/PGLs for determination of extent of disease.
Conference:
Presenting Author:
Authors: demirci e, ocak m, kabasakal l, yeyin n, asa s,
Keywords: Paragangliomas/Pheochromocytomas Gallium-68-DOTA-TATE,